Stem cells to treat lung disease in preterm infants

February 6, 2014

Advances in neonatal care for very preterm infants have greatly increased the chances of survival for these fragile infants. However, preterm infants have an increased risk of developing bronchopulmonary dysplasia (BPD), a serious lung disease, which is a major cause of death and lifelong complications. In a new study scheduled for publication in The Journal of Pediatrics, researchers evaluated the safety and feasibility of using stem cell therapies on very preterm infants to prevent or treat BPD.

Won Soon Park, MD, PhD, and colleagues from Samsung Medical Center and Biomedical Research Institute, Seoul, Republic of Korea, conducted a phase I, single-center trial of intratracheal transplantation of human umbilical cord blood-derived to nine very preterm infants (24-26 weeks gestational age) who were at high risk of developing BPD.

All patients who received the treatment tolerated the procedure well without any immediate serious adverse effects. Thirty-three percent of treated infants developed moderate BPD and none developed severe BPD, and 72 percent of a matched comparison group developed moderate or severe BPD. Another serious side effect of very , retinopathy of prematurity requiring surgery, tended to occur less often in treated infants. Overall, all nine treated infants survived to discharge, and only three developed moderate BPD.

This phase I study suggests that intratracheal administration of mesenchymal stem cells is safe and feasible. According to Dr. Park, "These findings strongly suggest that phase II clinical trials are warranted to test the efficacy of mesencymal stem cell transplantation, which could lead to new therapies to prevent or cure BPD." Dr. Park and colleagues are currently conducting a long-term safety and follow-up study of these nine ( NCT01632475).

Explore further: Antibiotic may prove beneficial to preterm infant lung health

More information: "Mesenchymal Stem Cells for Bronchopulmonary Dysplasia: Phase 1 Dose-Escalation Clinical Trial," by Yun Sil Chang, MD, PhD, So Yoon Ahn, MD, Hye Soo Yoo, MD, Se In Sung, MD, Soo Jin Choi, MD, PhD, Won Il Oh, MD, PhD, Woon Soon Park, MD, appears in The Journal of Pediatrics, DOI: 10.1016/j.jpeds.2013.12.011

Related Stories

ACOG: Delaying cord clamping advised for preterm infants

December 3, 2012

(HealthDay)—Evidence supports the benefits of delayed umbilical cord clamping for preterm infants, while for term infants, the evidence is unclear, according to a Committee Opinion published in the December issue of Obstetrics ...

Curcumin may protect premature infants' lungs

July 2, 2013

Turmeric, a key ingredient in spicy curry dishes, has long been known to have medicinal values. Now new research finds a substance in turmeric, curcumin, may provide lasting protection against potentially deadly lung damage ...

Recommended for you

Higher cigarette taxes linked to fewer infant deaths

December 1, 2015

Higher taxes and prices for cigarettes are strongly associated with lower infant mortality rates in the United States, according to a new study from Vanderbilt University and the University of Michigan released Dec. 1 in ...

Youth dance classes score low in physical activity

May 18, 2015

For parents who send their kids to dance classes to get some exercise, a new study from researchers at University of California, San Diego School of Medicine suggests most youth dance classes provide only limited amounts ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.